Skip to search.
 BSE Down 0.25% NSE Down 0.32%
Streaming
Ticker Tape: On

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

12.94 Up 0.33(2.62%) 9:19PM - Nasdaq Real Time Price

Add to Portfolio
Prev Close:12.61
Open:12.60
Bid:12.90 x 400
Ask:12.92 x 1900
1y Target Est:15.75
Beta:2.87
Next Earnings Date: 5-Aug-13CLDX Earnings announcement
Day's Range:12.60 - 13.00
52wk Range:3.91 - 14.09
Volume:351,458
Avg Vol (3m):1,772,030
Market Cap:1.05B
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for CLDX at this time.

Comparison

Symbol% ChgMkt Cap
CLDXUp 2.62%1.05B
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 0.80%11.87B
SUNPHARMA.NSUp 2.87%1.04T
GILD.MXUp 2.12%1.06T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):91.19
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.95
Quarterly EPS Est (Jun-13) :-0.22
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback